Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2865216 | The American Journal of the Medical Sciences | 2007 | 9 Pages |
Abstract
The selective vaccination strategy for HAV and HBV in our sample of patients with HCV is more cost-effective. However, the universal strategy is more effective and its ICE is minimal, thus it may be worth the additional cost.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rita MS, Matthew E. PhD, Manjunath A. Pharm D, Dennis W. PhD, Gireesh V. PhD, Antoine MD,